Woippy, March 4th, 2024 – ABL Diagnostics (FR001400AHX6), a leading molecular diagnostics company, has announced today that its parent company…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.